Abo Bibliothek: Guest
Digitales Portal Digitale Bibliothek eBooks Zeitschriften Referenzen und Berichte Forschungssammlungen
Critical Reviews™ in Biomedical Engineering
SJR: 0.26 SNIP: 0.375 CiteScore™: 1.4

ISSN Druckformat: 0278-940X
ISSN Online: 1943-619X

Volumes:
Volumen 48, 2020 Volumen 47, 2019 Volumen 46, 2018 Volumen 45, 2017 Volumen 44, 2016 Volumen 43, 2015 Volumen 42, 2014 Volumen 41, 2013 Volumen 40, 2012 Volumen 39, 2011 Volumen 38, 2010 Volumen 37, 2009 Volumen 36, 2008 Volumen 35, 2007 Volumen 34, 2006 Volumen 33, 2005 Volumen 32, 2004 Volumen 31, 2003 Volumen 30, 2002 Volumen 29, 2001 Volumen 28, 2000 Volumen 27, 1999 Volumen 26, 1998 Volumen 25, 1997 Volumen 24, 1996 Volumen 23, 1995

Critical Reviews™ in Biomedical Engineering

DOI: 10.1615/CritRevBiomedEng.2014011591
pages 249-270

Tissues Reborn: Fetal Membrane-Derived Matrices and Stem Cells in Orthopedic Regenerative Medicine

Renae Keeley
Laboratory of Orthopedic Tissue Regeneration & Orthobiologics, Department of Bioengineering, Clemson University, Clemson, South Carolina
Natasha Topoluk
Laboratory of Orthopedic Tissue Regeneration & Orthobiologics, Department of Bioengineering, Clemson University, Clemson, South Carolina
Jeremy Mercuri
Laboratory of Orthopedic Tissue Regeneration & Orthobiologics, Department of Bioengineering, Clemson University, Clemson, South Carolina

ABSTRAKT

The amniotic and chorionic membranes, as well as the stem cell populations contained within them, represent a widely available, versatile, and promising resource for use in numerous regenerative medicine applications. The primary focus of this review is to examine the use of the fetal membranes and/or their resident stem cell populations for regenerating orthopedic tissues. This discussion is prefaced by a brief synopsis of the structure, function, and biological properties of the extracellular matrix; embryological development; and a brief description of the distinct stem cell populations residing within the amniotic and chorionic membranes. Commercially available perinatal tissue allograft products available in the United States are reviewed, and a concise summary regarding the US Food and Drug Administration's current viewpoint on these technologies is provided. Concluding remarks regarding suggested future research directives for evaluating these tissues and stem cell sources in relation to orthopedic regenerative medicine applications also are presented.


Articles with similar content:

Abstract of "Ethical Challenges with the Development of Biotechnology-Derived Allergy Therapeutics"
Journal of Long-Term Effects of Medical Implants, Vol.18, 2008, issue 1
Jason Behrmann
Scaffolds: A Novel Carrier and Potential Wound Healer
Critical Reviews™ in Therapeutic Drug Carrier Systems, Vol.32, 2015, issue 4
Tarun Garg, Chetan Chaudhary
Strategies for Regeneration of Heart Muscle
Critical Reviews™ in Eukaryotic Gene Expression, Vol.20, 2010, issue 1
Glenn R. Gaudette, Ira S. Cohen, Jacques P. Guyette
Brain Shift Compensation and Neurosurgical Image Fusion Using Intraoperative MRI: Current Status and Future Challenges
Critical Reviews™ in Biomedical Engineering, Vol.40, 2012, issue 3
Miriam H. A. Bauer, Christopher Nimsky, Daniela Kuhnt
Bone Tissue Engineering: Recent Advances and Challenges
Critical Reviews™ in Biomedical Engineering, Vol.40, 2012, issue 5
Syam P. Nukavarapu, Cato T. Laurencin, Ami R. Amini